First Tracks CFO granted stock options, RSUs
First Tracks Biotherapeutics Chief Financial Officer Ajim Tamboli reported equity compensation awards in the form of stock options and restricted stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
First Tracks Biotherapeutics Chief Financial Officer Ajim Tamboli reported equity compensation awards in the form of stock options and restricted stock units. He received employee stock options to buy 41,234, 41,233 and 41,233 shares of common stock at exercise prices of $19.00, $18.87 and $17.00 per share, each expiring in 2036. He also received 45,700 restricted stock units, each representing the right to receive one share for no cash payment. The options vest 25% on April 20, 2027 and then monthly, while the RSUs vest 25% on the same date and then in equal annual installments, in each case contingent on continued service.
Insider Trade Summary
Grant/Award: 169,400 shares
Grant/Award
4 txns
Insider
Tamboli Ajim
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 41,234 | $0.00 | $0.00 |
| Grant/Award | Employee Stock Option (right to buy) | 41,233 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 45,700 | $0.00 | $0.00 |
| Grant/Award | Employee Stock Option (right to buy) | 41,233 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 45,700 contracts (Direct);
Employee Stock Option (right to buy) — 123,700 contracts (Direct)
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- F2. 1/4 of the RSUs shall vest on April 20, 2027 and 1/4th of the RSUs shall vest in equal annual installments until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- F3. The stock option vests as to 25% of the total shares on April 20, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Key Figures
Option grant 1: 41,234 options at $19.00
Option grant 2: 41,233 options at $18.87
Option grant 3: 41,233 options at $17.00
+2 more
5 metrics
Option grant 1
41,234 options at $19.00
Employee stock option, expires April 22, 2036
Option grant 2
41,233 options at $18.87
Employee stock option, expires April 21, 2036
Option grant 3
41,233 options at $17.00
Employee stock option, expires April 20, 2036
RSU grant
45,700 RSUs
Each RSU for 1 common share at settlement
Initial vesting date
April 20, 2027
25% of RSUs and options vest on this date
Key Terms
Restricted Stock Unit, Employee Stock Option, contingent right, vest, +1 more
5 terms
Restricted Stock Unit financial
"The stock option vests as to 25% of the total shares on April 20, 2027, and thereafter vests as to 1/48 of the total shares monthly..."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Option financial
"Employee Stock Option (right to buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
contingent right financial
"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock..."
vest financial
"1/4 of the RSUs shall vest on April 20, 2027 and 1/4th of the RSUs shall vest in equal annual installments..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price": "19.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did First Tracks Biotherapeutics (TRAXV) CFO report on this Form 4?
The CFO reported equity compensation awards. He received three blocks of employee stock options and a grant of 45,700 restricted stock units, all tied to First Tracks Biotherapeutics common stock and subject to future vesting conditions based on continued service.
How many stock options did the First Tracks (TRAXV) CFO receive?
He received three stock option grants covering 41,234, 41,233 and 41,233 shares. Each option is an employee stock option to buy First Tracks common stock at fixed exercise prices and has an expiration date in 2036, subject to vesting.
What are the exercise prices of the TRAXV CFO’s stock options?
The options have exercise prices of $19.00, $18.87 and $17.00 per share. These prices define the cost to purchase First Tracks Biotherapeutics common stock under each grant once the options are vested and exercisable, assuming other conditions are satisfied.
How many restricted stock units did the First Tracks (TRAXV) CFO receive?
He received 45,700 restricted stock units. Each RSU represents a contingent right to receive one share of First Tracks Biotherapeutics common stock upon settlement for no cash consideration, subject to vesting and continued service requirements described in the filing footnotes.
When do the TRAXV CFO’s RSUs and stock options start vesting?
Both the RSUs and stock options start vesting on April 20, 2027. One quarter of each award vests on that date, with the remaining RSUs vesting in equal annual installments and the options vesting monthly thereafter, conditioned on continued service.
Are the First Tracks (TRAXV) CFO awards tied to continued employment?
Yes. Vesting of both the RSUs and stock options requires continued service. The filing states that vesting on each date is subject to the reporting person’s provision of service to First Tracks Biotherapeutics, making these awards retention-focused compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates